COVID-19 Resource Center

Innovation is key to emerging from the COVID-19 pandemic and protecting that innovation with IP is essential. Here, we present our COVID-19-related information.

As the world grapples with the COVID-19 pandemic, our attorneys are helping clients navigate the complex intellectual property issues involved in developing testing, treatments, and vaccines, as well as related products and services to combat the disease. Additionally, our thought leaders are publishing articles, leading panel discussions, and serving as sources to the media in order to contribute to the global conversation about solutions to the crisis. Of course, innovation is key to emerging from the pandemic, and protecting that innovation is essential. Here, for your easy reference, we present our content related to COVID-19 and intellectual property considerations. Please do not hesitate to contact us for further information and/or to discuss your specific IP questions and concerns.

Related News & Insights

In the News

June 29, 2022

WTO Waiver Spurs In-House Fears of Broader Deals

Managing IP

In the News

December 17, 2021

Moderna Delays Bid for Covid Shot Patent Disputed by NIH

Bloomberg

Bylined Articles

August 17, 2021

Waiving Covid-19 Vaccine Patents Won’t Solve the Global Need

Bloomberg Law